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Fever  is  one of the  most common manifestations  of allergy to penicillin  (i).  In 
unsensitized individuals, the febrile  response typically appears on the 7th-10th day of 
drug administration, but occurs more rapidly in previously sensitized individuals  (2). 
Despite the frequency and clinical  importance of this phenomenon, the factors which 
produce penicillin  (PCN)i-induced fever do not appear to have been investigated. 
In a search for possible allergens  in the normal metabolism of benzylpenicillin G in 
the host, Levine (3-5)  has demonstrated that an initial  breakdown product,  benzyl- 
penicillenic  acid, may be metabolized  to the  benzylpenicilloyl (BPO)  hapten which 
produces cutaneous penicillin hypersensitivity in rabbits.  Further,  rabbits sensitized 
to  benzylpenicillin  develop  serum  antibodies  specific  to  BPO  as  demonstrated  by 
precipitin techniques (5, 6), passive cutaneous anaphylaxis (5, 7, 8), and hemagglutina- 
tion inhibition (9). 
Certain immediate reactions of hypersensitivity in man, such as anaphylaxis, have 
been shown to be caused primarily by minor penicillin determinants  such as benzyl- 
penicilloate, benzylpenicillamine, and penicilloate (7, 10, 11); reactions such as rashes, 
arthritis, and fever which appear later (12) are thought to be due to the BPO hapten. 
The nature of the antibody responsible for the allergic  reaction that produces fever 
has not been identified,  although the delay in onset of this reaction in sensitized in- 
dividuals suggests an antibody of the IgG class. 
The purpose of the experiments described here was to determine whether the 
penicilloyl hapten,  in the form of a  penicillin-rabbit  serum protein  conjugate, 
would produce fevers in rabbits sensitized to penicillin and, if so, to determine 
what immunologic factors might be responsible for the release of the endogenous 
pyrogen (EP)  that presumably mediates  this  as well as other forms of hyper- 
sensitivity fever (13). 
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Materials and Methods 
Equipment, Reagents, and Laboratory Utensils.--All glassware were rendered pyrogen-free  by 
heating in a dry air oven for 2 hr at 170°C. Water and normal saline were commercially ob- 
tained "pyrogen-free" (The Cutter Laboratories, Berkeley, Calif.). All solutions were periodi- 
cally tested in rabbits for pyrogenicity and cultured in thioglycollate broth (14). 
Animals.---Female  New Zealand white rabbits (3.5-5.5  kg) obtained from several commer- 
cial sources were used in all experiments. None was known to have been exposed to penicillin, 
though the breeders could not insure such a status. 
Penicillin Immunization.---A  benzylpenicillin G-complete adjuvant emulsion was prepared 
by thorough mixing of 100 mg (167,000 units) of potassium benzylpenicillin G  (E. R. Squibb 
and Sons, Princeton, N. J.) in 1 ml of water with 1 ml of complete Freund's adjuvant  (Difco 
Labs., Detroit, Mich.). 0.2 ml  of this emulsion was injected intradermally into  each of  10 
dorsal skin sites of rabbits. 10 days later, this procedure was repeated except that incomplete 
Freund's adjuvant (Difco Laboratories) was substituted  for complete adjuvant in the emulsion. 
8 days after the second inoculation, each animal received intravenously 100 mg of potassium 
benzylpenicillin G in 2 ml of water and 500,000  units of procaine penicillin (Squibb) intra- 
muscularly. These paired injections  were repeated four more times on every other day. Rabbits 
were used for experimentation 7-10 days after the last pair of injections (33-36 days after the 
initial immunization). This immunization regimen was modified from Levine and Ovary (5). 
Determination of Anti-Benzylpenicitlin  Hemagglutinating Antibody Titer.-- 
Serum collection: Before the start of immunization and before injection of penicillin on im- 
munization days, 1-3  ml of blood was obtained from the marginal ear vein of each rabbit. 
Immunized animals and nonpenicillin-immunized control animals were also bled before use. 
The blood was collected in centrifuge tubes, refrigerated for 1 hr at 4°C, and centrifuged at 
1500 rpm for 15 rain. The serum was removed and stored at -- 10°C. 
Preparation of penicillin-coated red blood cells: (Technique adapted from Thiel and Parker.) 
Alsever's solution, phosphate saline, and barbital buffer were prepared as described previously 
(15). 4 ml of blood from a rabbit was collected in a heparinized test tube. The red cells were 
then washed with a double volume of phosphate saline and centrifuged in the cold at 1500 rpm 
for 15 rain. This procedure was repeated three times. One volume of a 16% suspension of these 
cells in phosphate saline  was then added to 2.5 volumes of barbital buffer. To 3.5 volumes of 
this mixture was added 0.5 volumes of a 20 mg/ml solution of potassium benzylpenicillin G in 
phosphate saline.  For  control cells, 0.5  volumes of phosphate saline were added instead. 
Finally, both the control cells  and the penicillin-treated cells were incubated at  37°C  in  a 
water bath for 1 hr, and then at 4°C for 24 hr. After 24 hr, both pencillin-coated and control 
cells were washed with phosphate saline and centrifuged at  1500 rpm for 15 rain. This pro- 
cedure was repeated  (generally three times) until the supernatant was clear of hemoglobin. 
Hemagglntinatlon procedure: Two 0.4-ml aliquots of serum were serially diluted with phos- 
phate saline in plastic hemagglutination trays to produce two series of twofold serum dilutions 
up to 1: 2048. To one series was added 0.2 ml of 0.5% freshly washed pencillin-coated red blood 
cells in phosphate saline, prepared as above, and to the other was added control cells. The 
trays were shaken, allowed  to  rest at  room  temperature for 6-12  hr, and  then scored for 
hemagglutination, 0 to 4+. 
Preparation  of Penlcillin-Protein  Conjugates.--(Technique  adapted  from  Parker  [16].) 
Sterile techniques and materials were used for the conjugation procedure. A normal rabbit was 
exsanguinated by cardiac puncture and the serum obtained. This serum was lyophilized, and 4 
g  dissolved in a  few milliliters of sterile water. The concentrated serum solution was then 
adjusted to pH 7 with 5 N NaOH or dilute HC1 using a pH meter as a monitor. 40 ml of 1 
K2COa  (pH  10.4) buffer was then added followed  by  15.3 g  of powdered sodium  benzyl- 
pencillin G  (Squibb). The pH was finally adjusted to 9.6 with 5 N NaOH or dilute HC1, and 
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penicillin G were then added, the pH was readjusted to 11.0 using 5 N NaOH, and the solution 
was returned to the shaking water bath for 6 hr. The addition of sodium benzylpenicillin G 
(7.6 g), pH readjustment, and incubation was repeated once more. 
Dialysis of Penicillin-Protein Conjugate.--The penicillin-rabbit serum solution was poured 
into several 27  X  32  inch diameter cellulose  dialysis bags (Arthur H.  Thomas Co., Phila- 
delphia, Pa.) which had been previously rinsed well with sterile penicillin-protein  water. These 
bags were then suspended in a 4 liter beaker filled with 0.002 M tris(hydroxymethyl)amino- 
methane (Tris)  buffer, pH 7.9, to which had been added 3 g of Amberlite, 20-50 mesh. ]'_he 
Amberlite was previously prepared by soaking with 3 ~  NaOH, washing with sterile water, 
and equilibrating with 0.2 z~ Tris, pH 8.5. The dialysis bath was slowly stirred at 4°C with a 
magnetic mixer for 4 days, and fresh Tris buffer and Amberlite were used daily. A final 24 hr 
dialysis was carried out against 0.005 ~  Na~HPO4 buffer, pH 7.5-8.0.  The dialyzed material 
was then lyophilized, suspended in normal saline (7 g/100 cc saline), and stored at -- 10°C (17). 
Spectrophotometric Assay of Penicilloyl-Protein Conjugate.--O.l ml of penicillin-serum pro- 
tein conjugate was added to 100 ml of 0.05 g  K2CO3 (pH 9.2) buffer, and the optical density 
of this  solution  at  285  mp  measured with  a  Coleman  111  Spectrophotometer  (Coleman 
Instruments Division, Perkin-Elmer Corporation, Maywood, Ill.).  To  a  5  ml aliquot  was 
added 0.1 cc of a  1.5  X  10  -2 ~ p-chloromercuribenzoate (PCMB) solution, and after 10 rain 
of thorough shaking, the optical density was again measured. The first value, as well as the 
value for the PCMB  solution (0.060 OD  units), was subtracted from this reading, and  the 
result corrected for dilution by division by 1.02. The penieilloyl concentration in moles/liter 
was determined by dividing the corrected optical density by the molar extinction coefficient 
E  of penicilloyl-protein, 23,800  (17). The penicilloyl-rabbit protein conjugated used in these 
experiments varied in penicilloyl  concentration from 1.2  >(  10  -~ ~  to 4.7  )<  10  -2 ~t. 
Preparation of Rabbit Tissues.- 
Blood leukocytes and plasma: Donor rabbits previously sensitized to penicillin were anes- 
thetized with 100 mg of intravenous sodium pentobarbital and anti-coagulated with 10,000 
units of USP sodium heparin. The animals were then exsanguinated by cardiac puncture. The 
total number of white cells was calculated by hemaeytometer, and the blood centrifuged at 
1500 rpm for 15 rain.  The plasma was removed and saved for passive transfer experiments, 
while the cells were resuspended in sufficient modified Krebs-Ringer phosphate (KRP) buffer 
(18) containing 150% glucose to give a concentration of 1 X  107 WBC/ml. 
Spleen: After exsanguination of the animal, the spleen was removed and placed in iced 
saline.  It was then divided into several small segments and forced through a  No.  40  wire 
screen with a spatula and known volume of iced saline.  A leukocyte count was made using a 
hemacytometer, the suspension was spun at 1500 rpm for 15 min, the supernate removed, and 
the cells suspended in KRP buffer to a concentration of 2 >( l0  s WBC/ml. 
Challenge of Penicillin-Sensitized Rabbits.--Penicillin-sensitized rabbits  were  trained  in 
wooden boxes  during their immunization period. During experiments, they were placed in 
open wooden stalls and temperatures were taken every 15 min on a Foxboro rabbit scanning 
switch (The Foxboro Company, Foxboro, Mass.) and fever recorder equipped with thermistor 
probes (14). In general, rabbits were not challenged until their temperature was stable (within 
0.2°C) for a period of at least 1 hr. No animals were used whose temperatures were higher than 
40.5°C. At the time of challenge, the material used, usually 1-4 ml, was injected intravenously 
by marginal ear vein, and the subsequent temperatures recorded at  15-rain intervals for the 
next 3-4 hr. 
RESULTS 
Development  of  Circulating  Hemagglutinating  Anti-Benzylpenicillin  Anti- 
bodies in Penicillin-Immunized Rabbits.--Rabbits were immunized to penicillin 
according to  the regimen outlined in  Materials  and  Methods. Serum  samples 230  PENICILLIN-INDUCED  FEVER 
were obtained initially, and at approximately weekly intervals throughout and 
after immunization were tested for hemagglutinating anti-benzylpenicillin anti- 
bodies. Initial samples showed no detectable antibody in any of 27 rabbits. 1 of 
14 control animals had an initial titer (1/256).  After immunization, 26 of 27 
rabbits  developed  hemagglutinating  anti-benzylpenicillin  antibodies.  These 
antibodies typically appeared about day 15  in the immunization schedule, 5 
days  after  the  second  injection of penicillin in  Freund's  adjuvant.  Kemag- 
glutination titers tended to increase during the immunization process until day 
22 when they started to decline slightly. Fig. I  shows the distribution of the 
maximum anti-penicillin antibody titers developed in each animal during im- 
mnnization. 
4 
QB 
P) 
~2 
¢Q 
'5 
z  I 
0 
~44644  //H//, 
MM//, 
PZ//~ 
Z////~ 
,////1/ 
Y//S~ 
4  8  16  32  64 
RECIPROCAL 
tilT  J/ 
128  256 
HA  TITER 
Y/////A "//////" 
5t2  1024  2048  4096 
FIG.  1.  Maximum hemagglutinating (I-IA) anti-benzylpenicillin antibody titer developed in 
each of 27 penicillin-immunized animals. 
Since almost all rabbits (40/41) had no hemagglutinating anti-benzylpenicil- 
lin antibodies before penicillin immunization, the development of such anti- 
bodies in the experimental group was evidence of penicillin sensitization. It was 
next determined whether such sensitization would be accompanied by febrile 
response to antigen. 
Febrile Response of Penicillin-Immunized  Rabbits to Aqueous BcnzyIpenicil- 
lin.--17  rabbits immunized to benzylpenicillin G were challenged with intra- 
venous sodium benzylpenicillin G 15  20 days after receiving their last immuniz- 
ing dose of aqueous and intramuscular penicillin. Challenge doses varied from 
100,000  to 1,000,000  units. No rabbit developed a fever greater than 0.25°C, 
and none developed any sign of immediate allergic reaction to penicillin. Thus, 
animals sensitized by this immunization regimen did not develop immediate 
allergic reactions to parenterally administered aqueous penicillin, nor did they 
respond with significant fevers within 3 hr of such challenge. 
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venous Penicillin-Serum Protein Conjugates.--Since aqueous PCN alone did not 
produce fever in specifically immunized animals, a penicillin-rabbit serum pro- 
tein conjugate (BPO)  was prepared (see Materials and Methods). Immunized 
and normal rabbits were then challenged intravenously with varying amounts 
of this conjugate. As seen in Fig. 2, the penicillin-immunized animals responded 
with significant fevers, while the control animals remained afebrile. The fever 
appeared to be biphasic, with a small rapid peak at  15-30 min followed by a 
much larger one starting at about 75 rain after challenge. As shown in Fig. 3, 
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FIG. 2.  Mean febrile responses (-t-SEg) of penicillin-immunized and  unimmunized rabbit 
to intravenous challenge with 48 ~moles of pencillin-rabbit serum protein conjugate are com- 
pared. Numbers in parentheses in this and subsequent figures indicate the number of rabbits. 
there was a direct relationship between the amount of conjugate injected and 
the height of the fever. 
During these experiments, three immunized animals died after challenge with 
the conjugate. Approximately 30 sec after intravenous injection, these animals 
developed lateral nystagmus which was quickly followed by stridorous breath- 
ing, cyanosis of the mucous membranes, and screaming. Death ensued within 2 
rain. Necropsy of these animals revealed livers congested with blood and rela- 
tively bloodless lungs. 
In order to determine whether human serum conjugate would also elicit fever 
in rabbits,  100 #m of penicillin-human  serum protein  conjugate was injected 
into  two  penicillin-sensitized  animals  never previously injected  with  human 
materials. Two control animals without prior exposure to penicillin or human 
products were also challenged. The penicillin-immunized rabbits responded with 232  PENICILLIN-INDUCED  FEVER 
fevers sinfilar to those seen with  challenge  by penicillin-rabbit  serum protein 
conjugate, whereas control animals remained afebrile. 
From  these  experiments,  it  seems  apparent  that  animals  immunized  to 
penicillin,  unlike normal rabbits, develop fever after challenge with penicillin- 
serum protein conjugates, although not after challenge with simple intravenous 
aqueous penicillin. The main component of these fevers begins between 60 and 
2o -  T 
1,5 
;  •  12.u.M penicilloyl  an'tigen  (4) 
&~,,iL  24~M  (2) 
"~"  48p.M (4) 
X.--.---X  94~M  (2) 
A_ 
&T 
°C 
LO 
0.5 
0  ~ 
I  2  3 
CHALLENGE  HOURS 
FiG. 3.  Comparison of febrile responses (:t=SEM) of four groups of penicillin-immunized 
rabbits to intravenous challenge with four different doses of penicillin-rabbit serum protein 
conjugate. 
90 rain after injection,  and the height of fever varies directly with the dose of 
conjugate. Immunized animals appear to respond similarly to both human and 
rabbit serum penicillin conjugates. 
Development of Febrile Tolerance in Penicillin-Immunized Rabbits  after  Chal- 
lenge with Penicillin-Rabbit Serum Protein  Conjugate.--When  penicillin-hyper- 
sensitive rabbits received a second injection of penicillin-protein conjugate,  the 
second febrile response was much smaller than the first. Fig. 4 shows the  mean 
febrile responses  of eight penicillin-immunized  animals to  a  first injection  of 
penicillin-rabbit  serum protein  conjugate,  and  to  a  second  challenge  3  days 
later.  It is evident  that  an almost complete febrile tolerance developed  after MICHAEL  J.  CHUSID  AND  ELISHA  ATKINS  233 
the first injection. Repeated testing in some animals indicated that  tolerance 
usually lasted at least 2 wk. In 10 animals during the period of tolerance, one 
intramuscular injection of 600,000 units of procaine penicillin was given, and a 
challenge dose of conjugate 3 days later. Febrile responsiveness was partially 
restored by this boosting procedure in six  rabbits.  Thus,  tolerance appeared 
to  be  partially  reversible  by  reimmunization  with  intramuscular  procaine 
penicillin in some animals. 
Passive  Transfer of Penicillin  Hypersensitivity  with Plasma.--To determine 
whether febrile reactivity to penicillin could be passively transferred, unpooled 
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FI6. 4.  Initial  mean febrile  responses  (-t-SEM)  of  eight  penicillin-immunized  rabbits  to 
challenge with an average of 30 #moles penicillin-rabbit serum protein conjugate. Also shown is 
the mean febrile response (-t-sE~) of these same eight rabbits challenged 3 days later with a 
similar dose of conjugate. 
plasma obtained from three immunized rabbits was intravenously administered 
in doses of 20 ml to each of seven control animals (two or three recipients per 
donor). Mter plasma infusion and temperature stabilization for at least 2 hr, 
the recipient animals were challenged intravenously with penicillin-rabbit serum 
protein conjugate and their febrile responses recorded. Recipients of the hyper- 
sensitive plasma from two of the donor rabbits showed suggestive febrile re- 
sponses (0.3-0.4°C)  to challenge with 47/zm of penicillin-rabbit serum protein 
conjugate.  The recipients  of the  third  donor's plasma  were  given twice the 
dosage of antigen and showed a more definite febrile response (Fig. 5). Although 
fevers were small, perhaps because both the volume of plasma and the dosage 
of antigen given were relatively small,  the responses were all characteristic of 
antigen-induced fever. 
In Vitro Release of Endogenous Pyrogen from Tissues of Penicillin-Immunized 
Rabbits.--In  order to examine the  ability of cells from sensitized animals  to 
release EP in vitro in response to antigenic stimulation, blood and spleen cells 
from sensitized rabbits  were incubated with  penicillin-protein conjugate and 234  PENICILLIN-INDUCED  FEVER 
the supernatants assayed for EP. Blood leukocytes from penicillin-imnmnized 
animals, prepared as described in Materials and Methods,  were suspended in 
buffer with  serum from  either hypersensitive (HSS)  or  normal (NS)  rabbits. 
100 b~m of penicillin-rabbit  serum protein conjugate or 1 ml of saline was added 
to each suspension of cells. A dose of supernatant equivalent to about 1 X  l0  s 
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FIG. 5.  Mean febrile response of two unsensitized rabbits to intravenous challenge with 94 
/zmoles of penicillin-rabbit serum protein conjugate given after infusion of 20 ml of penicillin- 
hypersensitive plasma from a sensitized donor animal. 
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FIG. 6.  Mean maximal febrile responses (-4-SE~) of animals injected intravenously with 
supernates of blood cells from penicillin-immunized  rabbits. Cells were incubated with normal 
rabbit serum (NS) or penicillin-hypersensitive serum (HSS) and with (plus antigen Ag) and 
without the penicillin-rabbit serum protein conjugate. Doses were equivalent to 1 X l0  s white 
blood cells/dose (10 ml). The numbers in parentheses represent the number of animals injected. 
white  blood  ceils  was  injected  for  endogenous  pyrogen  assay  into  normal 
rabbits. 
As shown in Fig. 6, incubation of blood cells from penicillin-immunized  rab- 
bits with NS or HSS alone (lst and 3rd bars) did not produce endogenous pyro- 
gen release. Similarly, no pyrogen was released by the same blood cells incubated 
with  normal serum  (NS)  and penicillin-protein antigen (2nd bar).  However, 
endogenous pyrogen was released when blood cells were incubated with hyper- 
sensitive serum (HSS) and penicillin-protein  antigen (last bar). Injection of this 235 
AT 
°C 
supernate  produced  a  rapid  monophasic fever  typical  of endogenous pyrogen 
and  unlike  the  previously observed delayed responses  typical of antigen  in  a 
sensitized  host (Fig.  7).  Thus,  sensitized  blood cells released  pyrogen in vitro 
when incubated with both HSS and the penicillin-protein  conjugate. 
Analogous experiments  were  carried  out with  spleen  cells  obtained  from a 
penicillin-immunized  rabbit.  Unlike  the  blood  cells  of  penicillin-immunized 
rabbits,  the spleen cells from these same animals did not release pyrogen when 
incubated  with  penicillin-protein  antigen  and  either  hypersensitive  or normal 
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FIG. 7.  Characteristic febrile responses of a single rabbit  to supernates of white blood cells 
from a penicillin-immunized rabbit incubated with and without antigen. At (a) 10 ml of a con- 
trol supernate of white blood cells incubated with sensitized serum, buffer, and saline was given 
intravenously. At (b) I0 ml of experimental supernate of the same cells incubated with sensi- 
tized serum, buffer, and penicillin-protein antigen was injected. Both doses were equivalent to 
1 )< l0  s white blood cells. 
serum.  Supernatants  from  2  X  l0  s  cells  were  assayed  for  pyrogen  in  each 
experiment. 
DISCUSSION 
These studies demonstrate  that rabbits immunized  to penicillin  (PCN),  ac- 
cording to a regimen adapted from Levine and Ovary (5),  develop circulating 
antibody to benzylpenicillin,  but respond with fever and  anaphylaxis  only to 
penicillin-protein  conjugates  rather  than  to  PCN  itself.  Substances  with  a 
molecular weight  of  <1000  are  believed  to become immunogenic by binding 
irreversibly with  tissue macromolecules, presumably proteins  (19).  Since tem- 
peratures  were not measured  for more than  4  hr,  later  febrile  responses  that 236  PENICILLLN-INDUCED FEVER 
might have resulted from combination of penicillin with various proteins would 
not have been observed. 
Rarely, sensitized humans respond with rapid anaphylaxis to parenteral ad- 
ministration of penicillin. The difference between such  clinical situations and 
the experimental one described here may be due to differences in the rate of 
conjugation of penicillin with human and rabbit protein, the type or relative 
concentration of anti-penicillin antibodies in sensitized humans and rabbits, or 
a  greater vulnerability of humans to anaphylaxis. No data were obtained to 
support any of these alternatives. 
Because aqueous penicillin did not elicit fever or anaphylaxis in spedfically 
immunized animals, a penicillin-rabbit serum protein conjugate was prepared 
as the challenge antigen. This conjugate, prepared at high pH, according to a 
modification of the method of Parker and Thiel (16), was composed of benzyl- 
penicillin molecules joined to the lysine ~-amino groups of various rabbit serum 
proteins  via  benzylpenicilloyl (BPO)  linkages.  Intravenous  injection  of  the 
conjugate produced significant febrile responses  in penicillin-immunized ani- 
mals. The fevers were typically biphasic, with a small rapid peak evident 15-30 
min after challenge, and a larger febrile response beginning at 69-90 min after 
challenge. There appeared to be a rough correlation between the degree (height 
and duration) of the second (major) fever peak and the concentration of BPO 
injected. This later temperature rise closely resembled the febrile responses seen 
in  hypersensitivity  fevers,  such  as  those  induced  in  sensitized  rabbits  by 
staphylococcal filtrate (20), old tuberculin (21), bovine serum albumin (BSA) 
(22), and human serum albumin (HSA) (23), and thus appeared to represent a 
typical hypersensitivity fever. The significance of the smaller,  transient first 
peak  is  unclear.  Since  all  three  penicillin-immunized  rabbits  which  died  of 
anaphylaxis shortly after penicillin-protein challenge had rapidly rising  tem- 
peratures just before death, it may represent abortive anaphylactic response. 
Because there is no known humoral mediator that acts on the thermoregulatory 
center to produce a fever peak this rapidly (less than 30 min after challenge), 
such a response may result from a direct effect on the peripheral blood vessels 
or their nervous supply. This immediate, brief fever has not been described in 
other hypersensitivity fevers. 
Penicillin-immunized animals  also  responded with  fevers when  challenged 
with penicillin-human serum protein conjugate, indicating either a lack of car- 
rier  specificity as  opposed  to  hapten  specificity, or  cross-reactivity  between 
rabbit and human carrier protein. 
Since normal animals did not respond with fever to the PCN-protein con- 
jugate,  and  immunized  rabbits  rendered  endotoxin-tolerant by injections  of 
typhoid vaccine had undiminished responses to the antigen (data not included), 
the pyrogenicity of the conjugate was  clearly not due to contamination with 
endotoxin. 
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penicillin-protein conjugate resembled those occurring in other hypersensitiv- 
ity states associated with fever. For example, as in hypersensitivity to BSA 
(22-24)  and HSA (25), only animals with detectable titers of specific humoral 
antibodies had fever when challenged with antigen,  and the height of fever 
correlated roughly with the antibody titer. Further, as described in BSA-immu- 
nized rabbits (26), passive transfer of small amounts of plasma from penicillin- 
immunized animals enabled normal rabbits to respond with fever when chal- 
lenged with the penicillin-protein antigen. Also, as reported in hypersensitivity 
to BSA  (23),  HSA  (25),  or ovalbumin in sensitized guinea pigs  (27),  febrile 
tolerance  appeared  with  reinjection  of  antigen.  Unlike  the  tolerance  that 
develops to BSA hypersensitivity, however, febrile reactivity to antigen did 
not reappear after a rest of 3 or 4 days, and only one or two injections of the 
penicillin-protein  conjugate  antigen  induced  a  long-lasting  tolerant  state. 
Variations in the tolerance-inducing dose of antigen or in the degree of hyper- 
sensitivity developed by immunization may explain these differences. 
In  summary, the evidence presented here indicates that the BPO hapten- 
protein  conjugate  induces  significant,  dose-related  fevers  and,  occasionally, 
anaphylaxis in penicillin-immunized animals, while the PCN alone was inac- 
tive.  These  findings  suggest  that  the  hapten-protein  complex  may  be  the 
active agent in producing penicillin drug fever in man. 
In vitro experiments confirmed the ability of this conjugate to  induce EP 
release from sensitized blood cells in vitro. Since such cells failed to release gP 
when normal rabbit serum was substituted for sensitized serum, humoral anti- 
bodies seem clearly required for activation of leukocytes in this system. Ex- 
periments with normal blood leukocytes in this model were not done. 
In  these experiments with PCN,  like others using old tuberculin  (14,  28) 
and para-influenza virus  (29),  incubation of spleen  cells  with  the pyrogenic 
agent did not result in detectable EP release  in vitro. However, recent studies 
in rabbits with delayed hypersensitivity to bovine gamma globulin (30),  indi- 
cate that some antigens may activate specifically sensitized spleen cells to pro- 
duce EP in vitro when these cells are in  a fully supportive medium (Eagle's 
minimal essential medium). The mechanism appears to involve the release of a 
"lymphokine" activator from the lymphocytes in the cell suspensions. 
The sequence of events leading to the release of EP into the circulation after 
an intravenous dose of antigen in PCN-sensitized rabbits remains to be investi- 
gated. From these studies, it seems likely that anti-benzylpenicillin antibodies, 
probably  anti-benzylpenicilloyl  in  specificity,  are  initially  important.  Pre- 
sumably,  these  antibodies form  antigen-antibody complexes with  penicillin- 
protein antigen which are then phagocytized by host cells including blood leu- 
kocytes. Root and Wolff (31) have demonstrated that HSA-anti-HSA antigen- 
antibody complexes,  whether produced in vivo after injection of antigen Ag, 
or created in vitro in  the zone of Ag excess  and injected intravenously, are 
pyrogenic and mobilize detectable amounts of circulating EP.  Penicillin anti- 238  PENICILLIN-INDUCED  FEVER 
gen-antibody complexes  also  appear  to be pyrogenic, since  both  antigen  and 
antibody are  required  to induce fever or to release  EP from sensitized  blood 
leukocvtes in vitro.  The  exact  steps  by which  these  complexes  activate  cells 
to synthesize and release this substance is uncertain,  though antigen-antibody 
complexes  are  chemotactic  (32),  rapidly  phagocytized  (33,  34),  and  produce 
degranulation  and  membrane  permeability  changes  in  polymorphonuclear 
leukocytes in vitro (35). 
SUMMARY 
Rabbits  inmmnized  to benzylpeniciilin  G  responded  with fever when  chal- 
lenged with a penicillin-serum protein conjugate, but not with penicillin itself. 
After one or two challenges with  conjugate,  the  rabbits  became unresponsive 
(tolerant)  to further injections. This form of hypersensitivity was transferable 
with  plasma  of  immunized  donors  to  normal  rabbits.  Blood  leukocytes  of 
imnmnized  rabbits  incubated  with penicillin-protein  conjugate  and  hypersen- 
sitive serum released  endogenous pyrogen in vitro.  Spleen cells from the same 
animals,  on  the  other  hand,  were  inactive  when  incubated  with  this  antigen 
in  vitro.  These  experiments  appear  to be  the  first  to demonstrate  in  vitro  a 
possible mechanism of drug-induced fever. 
The authors would like to acknowledge the significant laboratory assistance provided by 
Mrs. Lorraine  Francis  and  Mrs.  Ann Bartiss  as well as  the helpful advice of Dr.  Phyllis 
Bodel. 
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